Description du projet
Un réseau de formation innovant espère élucider de nouvelles stratégies pour prévenir les cancers courants
Deux facteurs importants concernant le risque de développement d’un cancer sont l’inflammation chronique et les taux d’hormones sexuelles circulantes. Il y a plus de 150 ans, des scientifiques ont observé la présence de cellules inflammatoires à l’intérieur des tumeurs et que ces tumeurs surgissent aux endroits d’inflammation chronique, créant ainsi un lien présumé entre ces deux éléments. Des années d’études épidémiologiques indiquent désormais qu’un quart des cancers sont provoqués par une infection chronique ou d’autres types d’inflammations chroniques. En outre, il existe aujourd’hui une forte corrélation entre les taux d’hormones sexuelles circulantes et les cancers liés à l’appareil reproducteur féminin. Le projet CANCERPREV forme de jeunes chercheurs à des techniques de pointe, expérimentales et mathématiques, pour élaborer de nouvelles lignes directrices pour la prévention de cancers liés aux organes reproducteurs ou non reproducteurs.
Objectif
Incidence and prevalence of many cancer types are significantly increasing worldwide, with substantial differences between the sexes. Environmental influences in concert with genetic and epigenetic factors are still poorly understood.
Simultaneously, more sophisticated and expensive treatments cannot be afforded by society, increasing urgency of efforts in cancer prevention.
CANCERPREV is an innovative interdisciplinary research and training program gathering seven academic beneficiaries and nine partner organizations : (one leading pharmaceutical company, one leading technology company, a health insurance, an internationally known nursing school, three foundations and two universities) in nine European countries. CANCERPREV aims to establish new strategies in cancer prevention, with a focus on two key determinants of cancer risk: sex hormone signaling and chronic inflammation, in breast and skin as benchmarks of early steps of cancer development in organs with reproductive and non-reproductive functions, respectively.
Fifteen Early Stage Researchers (ESRs) will benefit from the complementary expertise of participating organizations and Principal Investigators in: basic cancer research, xenografts and genetic mouse models, bioinformatics and mathematical algorithms, epidemiology / human genetics, biomarkers, pharmacological approaches, behavioral / societal issues and outreach.
This network provides ESRs with unique future career opportunities in both academic and private sectors, through research training for PhD thesis projects with secondments and short and long visits to other participating research institutions, and yearly courses / formal lectures on various aspects of cancer prevention, including global health and occupational / behavioral issues. CANCERPREV will ensure that more knowledge and ideas are converted into products and services, and that a new generation of scientists is trained to contribute to the knowledge-based economy and society.
Champ scientifique
Mots‑clés
Programme(s)
Régime de financement
MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN)Coordinateur
1015 Lausanne
Suisse